Steven Halper
Stock Analyst at Cantor Fitzgerald
(4.22)
# 522
Out of 4,413 analysts
57
Total ratings
57.81%
Success rate
11.85%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $10.35 | +6.33% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $8.96 | +234.82% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $6.22 | +157.23% | 3 | Sep 14, 2023 | |
| RCM R1 RCM | Initiates: Overweight | $20 | $12.29 | +62.73% | 3 | Aug 15, 2023 | |
| AMWL American Well | Initiates: Overweight | n/a | $0.51 | - | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | n/a | $78.91 | - | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $26.81 | - | 2 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | n/a | $69.65 | - | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | n/a | $10.07 | - | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | n/a | $27.74 | - | 2 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | n/a | $12.75 | - | 7 | Apr 15, 2020 | |
| MDRX Veradigm | Reiterates: Neutral | n/a | $7.99 | - | 3 | Mar 3, 2020 | |
| EHTH eHealth | Reiterates: Overweight | n/a | $4.28 | - | 2 | Feb 21, 2020 | |
| CI Cigna | Reiterates: Overweight | n/a | $357.04 | - | 1 | Feb 6, 2020 | |
| HUM Humana | Reiterates: Overweight | n/a | $302.09 | - | 1 | Feb 5, 2020 | |
| PHR Phreesia | Initiates: Overweight | n/a | $20.74 | - | 1 | Jan 9, 2020 | |
| CNC Centene | Maintains: Overweight | n/a | $73.06 | - | 3 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $10.35
Upside: +6.33%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $8.96
Upside: +234.82%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $6.22
Upside: +157.23%
R1 RCM
Aug 15, 2023
Initiates: Overweight
Price Target: $20
Current: $12.29
Upside: +62.73%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: n/a
Current: $0.51
Upside: -
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $78.91
Upside: -
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $26.81
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: n/a
Current: $69.65
Upside: -
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: n/a
Current: $10.07
Upside: -
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $27.74
Upside: -
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: n/a
Current: $12.75
Upside: -
Veradigm
Mar 3, 2020
Reiterates: Neutral
Price Target: n/a
Current: $7.99
Upside: -
eHealth
Feb 21, 2020
Reiterates: Overweight
Price Target: n/a
Current: $4.28
Upside: -
Cigna
Feb 6, 2020
Reiterates: Overweight
Price Target: n/a
Current: $357.04
Upside: -
Humana
Feb 5, 2020
Reiterates: Overweight
Price Target: n/a
Current: $302.09
Upside: -
Phreesia
Jan 9, 2020
Initiates: Overweight
Price Target: n/a
Current: $20.74
Upside: -
Centene
Dec 17, 2018
Maintains: Overweight
Price Target: n/a
Current: $73.06
Upside: -